BridgeMD
New treatment option for Deep Touch Pressure
Official title Effects of Deep Touch Pressure on Emergence Agitation in Pediatric Patients
ClinicalTrials.gov ID: NCT06966466
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine if deep touch pressure (DTP) can reduce emergence agitation (EA) in pediatric patients aged 3 to 10 years undergoing tonsillectomy and adenoidectomy under general anesthesia. The main questions it aims to answer are: Does deep touch pressure (DTP) using a compression vest reduce the incidence of emergence agitation (EA) in the recovery room?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 10
You may be able to join if
- Pediatric patients aged 3 to 10 years scheduled for tonsillectomy and adenoidectomy under general anesthesia.
You likely can't join if
- Emergency surgery.
- Known neurological disorders (e.g., epilepsy, cerebral palsy).
- Skin disorders or injuries on the chest or upper body that prevent safe use of the compression vest (HUGgy).
- History of severe psychiatric disorders (e.g., autism spectrum disorder, severe anxiety disorder).
- History of severe allergic reactions to anesthesia.
- Any condition that, in the investigator's judgment, makes the patient unsuitable for the study.
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 10 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.